Featured Publications
Predictors of new persistent opioid use after benign hysterectomy in the United States
AlAshqar A, Ishiwata R, Moss C, Andersen KM, Yanek L, Bicket MC, Alexander GC, Borahay MA. Predictors of new persistent opioid use after benign hysterectomy in the United States. American Journal Of Obstetrics And Gynecology 2022, 227: 68.e1-68.e24. PMID: 35248573, PMCID: PMC9253094, DOI: 10.1016/j.ajog.2022.02.030.Peer-Reviewed Original ResearchConceptsNew persistent opioid usePersistent opioid usePerioperative opioid prescriptionOpioid usePerioperative prescriptionBenign hysterectomyOpioid prescriptionsSurgical complicationsClinical Classification Software codesNational insurance claims databaseLogistic regressionNew persistent usePrevalent opioid useRetrospective cohort studyInsurance Claims DatabaseMultivariate logistic regressionPersistent usePreoperative painCohort studyNaïve womenInvasive hysterectomyMedication usePain disordersSurgical indicationsTobacco smoking
2022
Cardiometabolic profile of women with uterine leiomyoma: a cross-sectional study.
Alashqar A, El Ouweini H, Gornet M, Yenokyan G, Borahay MA. Cardiometabolic profile of women with uterine leiomyoma: a cross-sectional study. Minerva Obstetrics And Gynecology 2022, 75: 27-38. PMID: 35333033, DOI: 10.23736/s2724-606x.22.04952-1.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesCross-Sectional StudiesFemaleHumansLeiomyomaRisk FactorsUterine NeoplasmsConceptsCardiometabolic risk factorsCardiometabolic comorbiditiesCross-sectional studyUterine leiomyomaCardiometabolic profileMedication useRisk factorsJohns Hopkins Health SystemEpic electronic medical record systemUnfavorable cardiometabolic profileCardiovascular disease preventionPrevalence odds ratiosUterine leiomyoma developmentElectronic medical record systemAssociated medicationsLeiomyoma riskMedical record systemOnly medicationEssential hypertensionMetabolic syndromeHospital encountersPrescription medicationsEarly managementOdds ratioLeiomyoma diagnosis
2019
Cardiometabolic Risk Factors and Benign Gynecologic Disorders.
AlAshqar A, Patzkowsky K, Afrin S, Wild R, Taylor HS, Borahay MA. Cardiometabolic Risk Factors and Benign Gynecologic Disorders. Obstetrical & Gynecological Survey 2019, 74: 661-673. PMID: 31755543, PMCID: PMC6986276, DOI: 10.1097/ogx.0000000000000718.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsCardiometabolic risk factorsBenign gynecologic disordersRisk factorsUterine leiomyomaGynecologic disordersUterine leiomyoma pathogenesisBenign gynecologic conditionsPolycystic ovarian syndromeExtracellular matrix depositionCardiometabolic riskOvarian syndromeSystemic inflammationAtherosclerotic changesChronic inflammationGynecologic conditionsHyperestrogenic stateVitamin DInsulin resistanceDietary factorsCardiovascular diseasePreventive strategiesTherapeutic interventionsLeiomyoma pathogenesisClinical implicationsEndometriosis